PROCEPT BIOROBOTICS CORP's ticker is and the CUSIP is 74276L105. A total of 125 filers reported holding PROCEPT BIOROBOTICS CORP in Q2 2023. The put-call ratio across all filers is 0.14 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $21,866,494 | +23.6% | 357,939 | 0.0% | 5.46% | +1260.8% |
| Q1 2024 | $17,689,345 | +17.9% | 357,939 | 0.0% | 0.40% | +17.3% |
| Q4 2023 | $15,001,223 | +27.7% | 357,939 | 0.0% | 0.34% | -92.1% |
| Q3 2023 | $11,743,979 | -7.2% | 357,939 | 0.0% | 4.33% | +10.1% |
| Q2 2023 | $12,653,144 | +24.5% | 357,939 | 0.0% | 3.93% | +18.8% |
| Q1 2023 | $10,165,468 | +68266.9% | 357,939 | 0.0% | 3.31% | -23.6% |
| Q4 2022 | $14,869 | -100.0% | 357,939 | -58.6% | 4.33% | -59.0% |
| Q3 2022 | $35,818,000 | +7.6% | 863,908 | -15.2% | 10.54% | +23.9% |
| Q2 2022 | $33,294,000 | -6.6% | 1,018,478 | 0.0% | 8.50% | +26.2% |
| Q1 2022 | $35,637,000 | +39.9% | 1,018,478 | 0.0% | 6.74% | +132.3% |
| Q4 2021 | $25,472,000 | -34.4% | 1,018,478 | 0.0% | 2.90% | -14.9% |
| Q3 2021 | $38,855,000 | – | 1,018,478 | – | 3.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 5,328,867 | $223,332,816 | 97.26% |
| Frank, Rimerman Advisors LLC | 456,953 | $19,150,900 | 4.00% |
| Robocap Asset Management Ltd | 97,824 | $4,099,804 | 3.13% |
| Eagle Health Investments LP | 337,218 | $14,132,806 | 2.87% |
| Point72 Europe (London) LLP | 530,071 | $22,215,276 | 2.78% |
| Taylor Frigon Capital Management LLC | 121,575 | $5,095,208 | 2.56% |
| Evolutionary Tree Capital Management, LLC | 49,106 | $2,058,032 | 2.27% |
| Rhenman & Partners Asset Management AB | 310,000 | $12,992,100 | 1.30% |
| AtonRa Partners | 14,715 | $616,706 | 1.23% |
| Lisanti Capital Growth, LLC | 121,690 | $5,100,028 | 1.20% |